Mark C. Schneyer
EVP, Chief Financial Officer at Acadia Pharmaceuticals · 11 reported transactions in 1 company · latest trade Aug 6, 2026
Their trades
Sold | Aug 6, 2026 | Aug 6, 2026 close $28.45 → Oct 26, 2026 close $19.74. S&P 500 −0.4% over the same days. | ||
Sold | Aug 6, 2026 | Aug 6, 2026 close $28.45 → Oct 26, 2026 close $19.74. S&P 500 −0.4% over the same days. | ||
Sold | Aug 5, 2026 | Aug 5, 2026 close $28.80 → Oct 26, 2026 close $19.74. S&P 500 −0.6% over the same days. | ||
Sold | Nov 18, 2025 | Nov 18, 2025 close $23.80 → Oct 26, 2026 close $19.74. S&P 500 +15.9% over the same days. | ||
Sold | Sep 15, 2025 | Sep 15, 2025 close $24.67 → Oct 26, 2026 close $19.74. S&P 500 +15.8% over the same days. |
$272.6K
Aug 6, 2026 close $28.45 → Oct 26, 2026 close $19.74. S&P 500 −0.4% over the same days.
$145K
Aug 6, 2026 close $28.45 → Oct 26, 2026 close $19.74. S&P 500 −0.4% over the same days.
$169.6K
Aug 5, 2026 close $28.80 → Oct 26, 2026 close $19.74. S&P 500 −0.6% over the same days.
$243.1K
Nov 18, 2025 close $23.80 → Oct 26, 2026 close $19.74. S&P 500 +15.9% over the same days.
$82.7K
Sep 15, 2025 close $24.67 → Oct 26, 2026 close $19.74. S&P 500 +15.8% over the same days.